142 related articles for article (PubMed ID: 38321586)
1. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
2. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
4. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
5. Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
Prabaharan H; Chandrasekaran S; Shetty N; Nayak K P
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417946
[TBL] [Abstract][Full Text] [Related]
6. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome.
Greensher JE; Louie J; Fish JD
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28926689
[TBL] [Abstract][Full Text] [Related]
8. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
Patel A; Fischer C; Lin YC; Basu EM; Kushner BH; De Braganca K; Khakoo Y
Pediatr Blood Cancer; 2020 Aug; 67(8):e28319. PubMed ID: 32543116
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus-ataxia syndrome in children.
Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
[TBL] [Abstract][Full Text] [Related]
10. The opsoclonus–myoclonus syndrome.
Sahu JK; Prasad K
Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
[TBL] [Abstract][Full Text] [Related]
11. Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.
Ghia T; Kanhangad M; Alessandri AJ; Price G; Gera P; Nagarajan L
Pediatr Neurol; 2016 Feb; 55():68-70. PubMed ID: 26778146
[TBL] [Abstract][Full Text] [Related]
12. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting.
Anand S; Agarwala S; Jain V; Bakhshi S; Dhua A; Gulati S; Seth R; Srinivas M; Jana M; Kandasamy D; Bhatnagar V
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e924-e929. PubMed ID: 33769388
[TBL] [Abstract][Full Text] [Related]
14. Surgical considerations for neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: a series of 14 patients from a single institution.
Johnston WR; Hwang R; Mattei P
Pediatr Surg Int; 2022 Feb; 38(2):249-255. PubMed ID: 34549330
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
[TBL] [Abstract][Full Text] [Related]
16. Opsoclonus-myoclonus syndrome.
Pike M
Handb Clin Neurol; 2013; 112():1209-11. PubMed ID: 23622330
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma-associated Opsoclonous Myoclonous Ataxia Syndrome: Profile and Outcome Report on 15 Egyptian Patients.
Elzomor H; El Menawi S; Elawady H; Elkinaai N; Elshafie M; Refaat A; Ghareeb H; Fawzy M
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e194-e199. PubMed ID: 35462382
[TBL] [Abstract][Full Text] [Related]
18. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
Nelson JL; Blume GM; Bansal SK; Kaufman JR; Woods FR; Zhang X; Kattah JC
J Neuroophthalmol; 2022 Jun; 42(2):251-255. PubMed ID: 34974489
[TBL] [Abstract][Full Text] [Related]
19. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
Gupta A; Kundal R; Pandey M
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
[TBL] [Abstract][Full Text] [Related]
20. [A case report on cervical neuroblastoma with ataxia].
Kanemura N; Nakano T; Hirano A; Amatsu H; Koshimo N; Uemura G; Aiba T
Nihon Jibiinkoka Gakkai Kaiho; 2011 May; 114(5):505-10. PubMed ID: 21702171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]